European Oncology Nursing Society (EONS)
The European Oncology Nursing Society (EONS) is an independent, not for profit pan-European organisation dedicated to the support and development of cancer nurses. Our mission is to ensure that all people affected by cancer benefit from the care of highly educated, well-informed and competent cancer nurses. Our vision is that cancer nursing will be recognised by the cancer community, national and European level policy makers, as a profession with specialised training and qualifications available across the continent. Working conditions for cancer nurses will be optimal, providing a commensurate financial income, protecting and promoting individual well-being and thus producing a relatable improvement in the health and clinical outcomes for people affected by cancer. Finally, we envisage that all our members will become confident and empowered cancer nurses operating as leaders in research, practice and education within multi-professional teams.
European Society for Medical Oncology (ESMO)
ESMO is the leading professional organisation for medical oncology. With more than 20,000 members representing oncology professionals from over 150 countries worldwide, ESMO is the society of reference for oncology education and information. ESMO is committed to offer the best care to people with cancer, through fostering integrated cancer care, supporting oncologists in their professional development, and advocating for sustainable cancer care worldwide.
- Booth Number: 4
European Society for Radiotherapy and Oncology (ESTRO)
Founded in 1980, ESTRO, the European SocieTy for Radiotherapy & Oncology, is a non-profit and scientific organisation that fosters the role of radiation oncology in order to improve patients’ care in the multimodality treatment of cancer.
ESTRO’s mission is to promote education, science, research and advocate for access to radiotherapy. Therefore the Society organises throughout the year teaching courses, workshops, meetings, and public affairs activities and publishes scientific material in its family of journals.
The Society counts over 7,300 members in and outside Europe and supports all the radiation oncology professionals and the wider oncology community in their daily practice.
European Society of Thoracic Surgeons (ESTS)
ESTS is the largest international general thoracic surgery organisation with more than 1600 members from all continents. The society’s mission is to improve quality in the specialty, from clinical and surgical management of patients to education, training and credentialing of thoracic surgeons worldwide.
The 27th European Conference on General Thoracic Surgery will be held on 9-12 June 2019 in Dublin, Ireland. Further information:
European Thoracic Oncology Platform (ETOP)
ETOP is a not-for-profit organization promoting academic clinical research and exchange of ideas in the field of thoracic oncology. ETOP sponsors and manages translational research projects and clinical trials with an emphasis on advancing the knowledge in thoracic malignancies. ETOP works with more than 200 collaborative groups and institutions from all over the world. More information available at:
International Association for the Study of Lung Cancer (IASLC)
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide.
- Booth Number: 5
Lung Cancer Europe is the voice of lung cancer people, their families and survivors at a European level.
LuCE aims to raise awareness about inequities regarding the access to treatments and care in Europe. Moreover, it advocates European policies in order to improve lung cancer prevention, early detection, treatment and care and supports national patient groups in helping raise awareness among the European public.
- Reduce the mortality of lung cancer
- Promote the best possible treatments
- Equal access to care throughout Europe
- Reduce the stigma of lung cancer
- Increase European funding allocated